|
MED28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.739590E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.044400E-01 |
| Normal-vs-Stage2 |
4.011700E-02 |
| Normal-vs-Stage3 |
1.090050E-01 |
| Normal-vs-Stage4 |
6.143400E-01 |
| Stage1-vs-Stage2 |
6.171800E-02 |
| Stage1-vs-Stage3 |
2.384200E-01 |
| Stage1-vs-Stage4 |
8.782800E-01 |
| Stage2-vs-Stage3 |
3.372200E-01 |
| Stage2-vs-Stage4 |
1.096640E-01 |
| Stage3-vs-Stage4 |
3.067200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.082800E-01 |
| Normal-vs-AfricanAmerican |
9.381400E-01 |
| Normal-vs-Asian |
6.710200E-01 |
| Caucasian-vs-AfricanAmerican |
6.173000E-01 |
| Caucasian-vs-Asian |
7.802200E-01 |
| AfricanAmerican-vs-Asian |
8.005800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.884300E-02 |
| Normal-vs-Female |
3.762400E-01 |
| Male-vs-Female |
5.641800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.922200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.557960E-01 |
| Normal-vs-Age(61-80Yrs) |
2.866000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.484000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.701240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.290300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.133600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.543000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.260200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.291400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.710400E-01 |
| Classical-VS-Follicular |
4.02290000001138E-06 |
| Classical-VS-Other |
7.768200E-01 |
| Classical-VS-Normal |
9.806000E-01 |
| Tall-VS-Follicular |
2.369900E-02 |
| Tall-VS-Other |
9.244000E-01 |
| Tall-VS-Normal |
6.174800E-01 |
| Follicular-VS-Other |
2.945400E-01 |
| Follicular-VS-Normal |
4.649900E-04 |
| Other-VS-Normal |
7.858400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.950200E-02 |
| Normal-vs-N1 |
3.271200E-01 |
| N0-vs-N1 |
6.138600E-01 |
|
|
